col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


37 Results       Page 1

 [1] 
Bentham Science: Current Medicinal Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2022―May―07 Chronic systemic low-grade inflammation and modern lifestyle: the dark role of gut microbiota on related diseases with a focus on pandemic COVID-19 Tiziana Mundula, Edda Russo, Lavinia Curini, Francesco Giudici, Andrea Piccioni, Francesco Franceschi, Amedeo Amedei
2 [GO] 2022―Mar―02 COVID-19 Effects on Geriatric Populationand Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccinesin the Prevention & Treatment of COVID-19 Narasimha M. Beeraka, SubbaRao V Tulimilli, M V Greeshma, Siva Dallavalasa, Yaowen Zhang, Wenjing Xiao, et al. (+6)
3 [GO] 2022―Feb―16 Perspectives and Prospects on mRNA Vaccine Development for COVID-19 Lihui Jin, Zhenyuan Han, Pengjun Zhao, Kun Sun
4 [GO] 2022―Feb―14 Aptamer-based Emerging Tools for Viral Biomarker Detection: A focus on SARS-CoV-2 Prabir Kumar Kulabhusan, Parsa Pishva, Eda Çapkın, Prajakta Tambe, Meral Yüce
5 [GO] 2021―Oct―27 The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis Stamatios Lampsas, Paraskevas Tsaplaris, Panteleimon Pantelidis, Evangelos Oikonomou, Georgios Marinos, Georgios Charalambous, et al. (+9)
6 [GO] 2021―Sep―02 The impact of Vaccination worldwide on SARS-CoV-2 infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants Douglas Henrique Pereira Damasceno, Arthur Aguiar Amaral, Cecília Andrade Silva, Ana Cristina Simões e Silva
7 [GO] 2021―Aug―23 Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) Shabana Bibi, Mohammad Mehedi Hasan, Yuan-Bing Wang, Stavros P. Papadakos, Hong Yu
8 [GO] 2021―Jul―27 Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2 Luana N. O. Leal da Cunha, Tiago Tizziani, Gabriella B. Souza, Monalisa A. Moreira, José S. S. Neto, Carlos V. D. dos Santos, et al. (+8)
9 [GO] 2021―Jun―24 Interfering Reactive Cysteine Proteome in Covid-19 Disease Marcos Martinez-Banaclocha
10 [GO] 2021―Jun―15 Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects Davide Gentile, Vincenzo Patamia, Virginia Fuochi, Pio M. Furneri, Antonio Rescifina
11 [GO] 2021―May―27 COVID-19: The significance of platelets, mitochondria, vitamin D, serotonin and the gut microbiota István Bókkon, Gábor Kapócs, András Vucskits, Attila Erdöfi-Szabó, Jan Vagedes, Felix Scholkman, Henrik Szőke
12 [GO] 2021―May―27 Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy Patrick Müller, Hannah Maus, Stefan Josef Hammerschmidt, Philip Knaff, Volker Mailänder, Tanja Schirmeister, Christian Kersten
13 [GO] 2021―May―22 Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello
14 [GO] 2021―May―10 SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm That Implicates For Therapeutic Strategies Zhao-Zhong Chong, Nizar Souayah
15 [GO] 2021―May―05 Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics Rahul Sharma, Dharmendra Khokhar, Bhanushree Gupta, Purnendu Saxena, Kallol Kumar Ghosh, Arvind Kumar Geda, Kamil Kuca
16 [GO] 2021―Apr―06 The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis Alice Barros Câmara, Igor Augusto Brandão
17 [GO] 2021―Mar―30 Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2 Walter Filgueira de Azevedo Junior, Gabriela Bitencourt-Ferreira, Joana Retzke Godoy, Hilda Mayela Aran Adriano, Wallyson André dos Santos Bezerra, Alexandra Martins dos Santos Soares
18 [GO] 2021―Feb―19 Advances of Inorganic Materials in the Detection and Therapeutic Uses Against Coronaviruses Sathish Veerasamy, Manivannan Chandrakumar, Malathi Balasubramaniyan, Ramesh Kumar Arumugam, Thanasekaran Pounraj
19 [GO] 2021―Feb―15 Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19 Katharina Lanza, Raphael Dias, Rafaela dos Santos Oliveira, Luís Belotto, Aline Silva Miranda, Ana Cristina Simões e Silva
20 [GO] 2021―Feb―10 Nucleoside Inhibitors of Coronaviruses Anastasia A. Zenchenko, Mikhail S. Drenichev, Sergey N. Mikhailov
21 [GO] 2021―Jan―26 Natural Products as Potential Agents Against SARS-CoV and SARS-CoV-2 Joanda Paolla Raimundo e Silva, Chonny Alexander Herrera Acevedo, Thalisson Amorim de Souza, Renata Priscila Barros de Menezes, Zoe L. Sessions, Lucas Silva Abreu, et al. (+6)
22 [GO] 2021―Jan―14 Deep learning in the quest for compound nomination for fighting COVID-19 Maria Mernea, Eliza. C. Martin, Andrei-José Petrescu, Speranta Avram
23 [GO] 2021―Jan―08 Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19 Sumera Zaib, Nehal Rana, Areeba Noor, Imtiaz Khan
24 [GO] 2020―Dec―10 The role of Interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19 Ilias Giannakodimos, Georgia-Vasiliki Gkountana, Dimosthenis Lykouras, Kiriakos Karkoulias, Sotiris Tsakas
25 [GO] 2020―Oct―28 COVID-19 vaccine race: analysis of age-dependent immune responses against SARS-CoV-2 indicates that more than just one strategy may be needed. Nuria E. Campillo, Mercedes Jimenez, Matilde Canelles
26 [GO] 2020―Oct―28 COVID-19: innovative antiviral drugs required for long-term prevention and control of coronavirus diseases Norman A. Ratcliffe, Helena C. Castro, Izabel C. Paixão, Cicero B. Mello
27 [GO] 2020―Oct―28 Recent Advances towards Drug Design Targeting the Protease of 2019 novel coronavirus (2019-nCoV) Sehrish Bano, Abdul Hameed, Mariya Al-Rashida, Shafia Iftikhar, Jamshed Iqbal
28 [GO] 2020―Oct―27 Evidence and the main adverse effects regarding drug therapies in the war against COVID-19 Mauricio Mora-Ramírez, Paulina Melgoza-Hernández, Sebastian Eduardo Toledo-Ramírez, Juan Manuel Mejía Aranguré
29 [GO] 2020―Oct―06 COVID-19 related coagulopathy: what is known up to now Ana Luísa Batista Pena, Rafael Arantes Oliveira, Renata Gomes Severo, Ana Cristina Simões e Silva
30 [GO] 2020―Sep―09 Current scenario and future prospect in the management of COVID-19 Pobitra Borah, Pran Kishore Deb, Satyendra Deka, Katharigatta N. Venugopala, Vinayak Singh, Raghu Prasad Mailavaram, et al. (+2)
31 [GO] 2020―Sep―05 Targeting COVID-19 in Parkinson’s patients: Drugs repurposed. Firoz Anwar, Salma Naqvi, Fahad A. Al-Abbasi, Nauroz Neelofar, Vikas Kumar, Ankit Sahoo, Mohammad Amjad Kamal
32 [GO] 2020―Sep―03 Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19 Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Cristina Cerqueira Vieira, Lucas Crepaldi Carvalho Nery, Raphael Figuiredo Dias, Ana Cristina Simões e Silva
33 [GO] 2020―Jul―22 Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19 Mark Laws, Yasmin M. Surani, Md. Mahbub Hasan, Yiyuan Chen, Peiqin Jin, Taha AlAdhami, et al. (+6)
34 [GO] 2020―Jul―11 Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions Anil K. Sharma, Varruchi Sharma, Arun Sharma, Suresh Pallikkuth
35 [GO] 2020―Jul―02 The chronicle of COVID-19: possible strategies to curb the pandemic Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Githa Elizabeth Mathew, Simone Carradori, Bijo Mathew
36 [GO] 2020―May―13 In vitro data of current therapies for SARS-CoV-2 Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Dimitrios Tsilingiris, Nikolaos Tentolouris
37 [GO] 2020―Apr―16 SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni Nicola Roviello
 [1] 

37 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec